DNMT3A and aortic stenosis: In a cohort of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), TET2- and DNMT3A-driven CHIP was found to be associated with a profound mortality risk even after successful TAVI [8].